|Project Title||The U.S. Food and Drug Administration's Mini-Sentinel Program: Status and Direction|
Thursday, January 19, 2012
This paper provides an overview of the development, current status, and direction of the FDA’s Mini-Sentinel pilot, including methods, tools, resources, policies, and procedures to facilitate the use of routinely collected electronic healthcare data to perform active surveillance of the safety of marketed medical products, including drugs, biologics, and medical devices.
- Vaccines, Blood & Biologics
- Devices and Radiologic Health